Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
JACC. Cardiovascular Interventions|February 7, 2025
Randomized Trial of Biolimus DCB for In-Stent Restenosis: The Primary Results of the REFORM StudyRobert A Byrne, Joo-Yong Hahn, Peter O'Kane, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 16, 2023
Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM)Bryan P Traynor, Sean Fitzgerald, Fernando Alfonso, et al.
The American Journal of Cardiology|September 2, 2021
Relation of High-Sensitivity Troponin to 1 Year Mortality in 20,000 Consecutive Hospital Patients Undergoing a Blood Test for Any ReasonJonathan Hinton, Mark Mariathas, Lavinia Gabara, et al.
JACC. Cardiovascular Imaging|March 18, 2019
Spontaneous Coronary Artery Dissection: Pathophysiological Insights From Optical Coherence TomographyRobert Jackson, Abtehale Al-Hussaini, Shiju Joseph, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2026
Optical coherence tomography versus angiographic guidance in true unprotected left main bifurcation disease: an OCTOBER substudyEmil N Holck, Lene D Andreasen, Omeed Neghabat, et al.
Journal of the American College of Cardiology|May 17, 2024
Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic CardiomyopathySaad M Ezad, Margaret McEntegart, Matthew Dodd, et al.
Heart (British Cardiac Society)|August 7, 2023
Association between troponin level and medium-term mortality in 20 000 hospital patientsJonathan Hinton, Mark Nihal Mariathas, Lavinia Gabara, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trialRobert-Jan van Geuns, Chang Chun-Chin, Margaret B McEntegart, et al.
Journal of Cardiovascular Computed Tomography|October 10, 2022
Randomized comparison of chest pain evaluation with FFRCT or standard care: Factors determining US costsMark A Hlatky, Sam Wilding, Beth Stuart, et al.
Pageof 11